Literature DB >> 28110902

Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.

Ella F Jones1, Kimberly M Ray2, Wen Li2, Youngho Seo2, Benjamin L Franc2, Amy J Chien3, Laura J Esserman4, Miguel H Pampaloni2, Bonnie N Joe2, Nola M Hylton2.   

Abstract

Entities:  

Keywords:  ER(+); Imaging; MRI; MammiPET; Triple negative

Mesh：

Substances：

Year:  2016        PMID： 28110902      PMCID： PMC7337237          DOI： 10.1016/j.clbc.2016.12.008

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  19 in total

1.  Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.

Authors:  Yuting Wang; Chengpeng Zhang; Jianjun Liu; Gang Huang
Journal:  Breast Cancer Res Treat       Date:  2011-09-30       Impact factor: 4.872

2.  I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.

Authors:  A D Barker; C C Sigman; G J Kelloff; N M Hylton; D A Berry; L J Esserman
Journal:  Clin Pharmacol Ther       Date:  2009-05-13       Impact factor: 6.875

3.  The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.

Authors:  David Groheux; Sylvie Giacchetti; Marc Espié; Laetitia Vercellino; Anne-Sophie Hamy; Marc Delord; Nathalie Berenger; Marie-Elisabeth Toubert; Jean-Louis Misset; Elif Hindié
Journal:  J Nucl Med       Date:  2011-08-30       Impact factor: 10.057

Review 4.  Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.

Authors:  Xiangnan Kong; Meena S Moran; Ning Zhang; Bruce Haffty; Qifeng Yang
Journal:  Eur J Cancer       Date:  2011-07-05       Impact factor: 9.162

5.  Design and evaluation of the MAMMI dedicated breast PET.

Authors:  L Moliner; A J Gonzalez; A Soriano; F Sanchez; C Correcher; A Orero; M Carles; L F Vidal; J Barbera; L Caballero; M Seimetz; C Vazquez; J M Benlloch
Journal:  Med Phys       Date:  2012-09       Impact factor: 4.071

6.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Authors:  Nola M Hylton; Jeffrey D Blume; Wanda K Bernreuter; Etta D Pisano; Mark A Rosen; Elizabeth A Morris; Paul T Weatherall; Constance D Lehman; Gillian M Newstead; Sandra Polin; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

7.  Heterogeneity in breast cancer.

Authors:  Kornelia Polyak
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

8.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 9.  Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Authors:  Patricia Cortazar; Lijun Zhang; Michael Untch; Keyur Mehta; Joseph P Costantino; Norman Wolmark; Hervé Bonnefoi; David Cameron; Luca Gianni; Pinuccia Valagussa; Sandra M Swain; Tatiana Prowell; Sibylle Loibl; D Lawrence Wickerham; Jan Bogaerts; Jose Baselga; Charles Perou; Gideon Blumenthal; Jens Blohmer; Eleftherios P Mamounas; Jonas Bergh; Vladimir Semiglazov; Robert Justice; Holger Eidtmann; Soonmyung Paik; Martine Piccart; Rajeshwari Sridhara; Peter A Fasching; Leen Slaets; Shenghui Tang; Bernd Gerber; Charles E Geyer; Richard Pazdur; Nina Ditsch; Priya Rastogi; Wolfgang Eiermann; Gunter von Minckwitz
Journal:  Lancet       Date:  2014-02-14       Impact factor: 79.321

10.  Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging.

Authors:  Marjan S Bolouri; Sjoerd G Elias; Dorota J Wisner; Spencer C Behr; Randall A Hawkins; Sachiko A Suzuki; Krysta S Banfield; Bonnie N Joe; Nola M Hylton
Journal:  Radiology       Date:  2013-07-22       Impact factor: 11.105
View more
  5 in total

1.  Diagnostic performance of dedicated breast positron emission tomography.

Authors:  Rikako Hashimoto; Sadako Akashi-Tanaka; Chie Watanabe; Hiroko Masuda; Kanae Taruno; Tomoko Takamaru; Yoshimi Ide; Takashi Kuwayama; Yasuhiro Kobayashi; Masafumi Takimoto; Seigo Nakamura
Journal:  Breast Cancer       Date:  2022-06-29       Impact factor: 3.307

2.  Development of High-Resolution Dedicated PET-Based Radiomics Machine Learning Model to Predict Axillary Lymph Node Status in Early-Stage Breast Cancer.

Authors:  Jingyi Cheng; Caiyue Ren; Guangyu Liu; Ruohong Shui; Yingjian Zhang; Junjie Li; Zhimin Shao
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

3.  Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.

Authors:  Deep K Hathi; Wen Li; Youngho Seo; Robert R Flavell; John Kornak; Benjamin L Franc; Bonnie N Joe; Laura J Esserman; Nola M Hylton; Ella F Jones
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

Review 4.  Microwave Sensors for Breast Cancer Detection.

Authors:  Lulu Wang
Journal:  Sensors (Basel)       Date:  2018-02-23       Impact factor: 3.576

Review 5.  Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.

Authors:  Ella F Jones; Deep K Hathi; Rita Freimanis; Rita A Mukhtar; A Jo Chien; Laura J Esserman; Laura J Van't Veer; Bonnie N Joe; Nola M Hylton
Journal:  Cancers (Basel)       Date:  2020-06-09       Impact factor: 6.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.